1Carol Aghajanian.The role of bevacizumab in ovarian cancer—An evolving story[J].Gynecologic Oncology.2006(2)
2Van Cutsem Eric,Vervenne Walter L,Bennouna Jaafar,Humblet Yves,Gill Sharlene,Van Laethem Jean-Luc,Verslype Chris,Scheithauer Werner,Shang Aijing,Cosaert Jan,Moore Malcolm J.Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer[].Journal of clinical oncology : official journal of the American Society of Clinical Oncology.2009
3Garcia Agustin A,Hirte Hal,Fleming Gini,Yang Dongyun,Tsao-Wei Denice D,Roman Lynda,Groshen Susan,Swenson Steve,Markland Frank,Gandara David,Scudder Sidney,Morgan Robert,Chen Helen,Lenz Heinz-Josef,Oza Amit M.Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia[].Journal of clinical oncology : official journal of the American Society of Clinical Oncology.2008
4American Society of Hospital Pharmacists.ASHP statement on the use Of medications for unlabeled users[].Am J Hospital Pharm.1992
5D.Aguiar Bujanda.Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. http://annonc.oxfordjournals.org .
6Kelsen D,Jhawer M,Ilson D,et al.Analysis of survival with modified docetaxel,cisplatin,fluorouracil (mDCF),and bevacizumab (BEV)in patients with metastatic gastroesophageal (GE)adenocarcinoma:results of a phase II clinical trial[].Journal of Clinical Oncology.2009
7El-Rayes BF,Patel B,Zalupski M,et al.A phase II study of bevacizumab,docetaxel,and oxaliplatin in gastric and GEJ cancer[].Journal of Clinical Oncology.2009
8Kindler HL,Niedzwiecki D,Hollis D,et al.A doubleblind,placebo controlled,randomized phaseⅢtrial of gemcitabine (G)plus bevacizumab (B)versus gemcitabine plus placebo (P)in patients (pts)with advanced pancreatic cancer (PC):a preliminary analysis of Cancer and Leukemia Group B (CALGB)[].Journal of Clinical Oncology.2007
